Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Characterization of urinary bile acids in a pediatric BRIC-1 patient: effect of rifampicin treatment.
[benign recurrent intrahepatic cholestasis]
Benign
recurrent
intrahepatic
cholestasis
type
1
(
BRIC
-
1
)
,
a
rare
autosomal
recessive
disorder
characterized
by
recurrent
episodes
of
jaundice
and
pruritus
,
is
caused
by
mutations
in
the
ATP
8
B
1
gene
.
Rifampicin
has
been
reported
to
be
an
effective
treatment
of
jaundice
and
pruritus
in
patients
with
BRIC
.
Proposed
mechanisms
of
effect
for
rifampicin
include
enhancement
of
multidrug-resistance
protein
2
expression
,
activation
of
the
enzymes
of
uridine
diphosphate
glucuronosyltransferase
1
A
1
and
cytochrome
P
450
3
A
4
,
and
stimulation
of
6
α-hydroxylation
of
bile
acids
.
To
confirm
the
diagnosis
of
BRIC
-
1
and
demonstrate
the
effect
of
rifampicin
treatment
on
bile
acid
metabolism
,
we
analyzed
the
patient
's
ATP
8
B
1
gene
and
bile
acids
in
urine
.
We
detected
2
heterozygous
mutations
in
the
ATP
8
B
1
gene
,
and
increasing
amounts
of
unusual
bile
acids
such
as
1
β-hydroxylated
cholic
acid
,
2
β-hydroxylated
cholic
acid
,
4
β-hydroxylated
cholic
acid
,
6
α-hydroxylated
cholic
acid
,
and
hyocholic
acid
in
urine
during
rifampicin
treatment
.
We
diagnosed
a
jaundiced
pediatric
patient
with
BRIC
-
1
caused
by
2
novel
mutations
(
1226
delA
/
2210
delA
)
in
the
ATP
8
B
1
gene
.
Rifampicin
was
effective
in
treating
cholestasis
.
Results
of
urinary
bile
acid
analyses
during
rifampicin
treatment
in
this
patient
,
suggested
that
rifampicin
might
stimulate
1
β-
,
2
β-
,
and
4
β-hydroxylation
of
bile
acids
in
addition
to
6
α-hydroxylation
.
Diseases
Validation
Diseases presenting
"recurrent episodes"
symptom
acute rheumatic fever
adrenomyeloneuropathy
benign recurrent intrahepatic cholestasis
child syndrome
cholangiocarcinoma
cystinuria
familial mediterranean fever
hydrocephalus with stenosis of the aqueduct of sylvius
kabuki syndrome
neuralgic amyotrophy
pyruvate dehydrogenase deficiency
systemic capillary leak syndrome
triple a syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom